Beyond the Cysts: The Real Story of PMOS
The renaming of PCOS to PMOS is the most consequential disease-nomenclature overhaul in a generation For decades, clinicians and patients have…
Your Ozempic Patients Are Drinking Less, Here’s Why That’s Not a Coincidence
A landmark RCT is changing the conversation around alcohol use disorder The numbers that stopped addiction specialists mid-sentence The most…
Is Zone 2 Training Really the Mitochondrial Holy Grail?
Consistency beats perfection for mitochondrial health. The Rise of a “Perfect” Training Zone For decades, Zone 2 training occupied a niche…
Cholesterol Rules Rewritten: The 2026 Lipid Guidelines Revolution
New equations, lower targets, and mandatory Lp(a) testing. A Game-Changer in Cardiovascular Prevention After nearly a decade, the…
The 2026–2027 Patent Cliff: Pharmacy’s Next Inflection Point
Over the next 24 months, one of the most under-discussed shifts in healthcare will quietly unfold. You’ve probably heard the phrase…